BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited (ASX: BDX) has requested a trading halt on its securities as the company prepares for a capital raising event, anticipated to conclude by Friday, 31 May 2024. The halt is also in response to an ASX Price Query letter, with the company undertaking a bookbuild to facilitate the fundraising process. Investors are keenly awaiting further announcements from BCAL on the outcome of the capital raising initiative.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
